Share ownership Eli Lilly and Company

LLY

US5324571083

Pharmaceuticals

Market Closed - Nyse Other stock markets 21:00:02 12/05/2026 BST			Pre-market 11:00:13
989.87 ^USD	+2.37%		992.00	+0.22%

10:55am	Eli Lilly India says Lilly's Alzheimer's drug donanemab is expected to be available in India in May	RE
10:29am	Eli Lilly launches Alzheimer's drug Donanemab in India	RE

Share class: Eli Lilly and Company

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	941,741,406	940,093,925 ( 99.83 %)	0	99.83 %

Major shareholders: Eli Lilly and Company

Name	Equities	%	Valuation
Lilly Endowment, Inc. 9.758 %	91,896,978	9.758 %	85 887 M $
Lilly Endowment, Inc. 9.757 %	91,881,150	9.757 %	85 872 M $
Vanguard Capital Management LLC 6.509 %	61,295,605	6.509 %	57 287 M $
Vanguard Capital Management LLC 5.666 %	53,361,774	5.666 %	49 872 M $
PNC Wealth Management LLC 5.429 %	51,125,662	5.429 %	47 782 M $
BlackRock Advisors LLC 5.311 %	50,014,607	5.311 %	46 744 M $
STATE STREET CORPORATION 3.755 %	35,361,916	3.755 %	33 049 M $
Fidelity Management & Research Co. LLC 2.727 %	25,684,557	2.727 %	24 005 M $
Capital Research & Management Co. (Global Investors) 2.609 %	24,566,846	2.609 %	22 960 M $
Vanguard Portfolio Management LLC 2.227 %	20,977,027	2.227 %	19 605 M $
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Name	Equities	%	Valuation
Caixa DTVM SA 0.001039 %	293,920	0.001039 %	9 M $
Safra Asset CTVM SA (Investment Management) 0.000135 %	38,300	0.000135 %	1 M $
XP Allocation Asset Management Ltda. 0.000032 %	8,996	0.000032 %	278 958 $
Empiricus Gestao De Recursos Ltda. 0.000026 %	7,333	0.000026 %	227 390 $
XP Advisory Gestão Recursos Ltda. 0.000021 %	5,925	0.000021 %	183 729 $
Santa Fé Investimentos Ltda 0.000014 %	3,870	0.000014 %	120 005 $
BTG Pactual Gestão E Consultoria De Investimentos Ltda. 0.000008 %	2,290	0.000008 %	71 011 $
Santander Distribuidora de Titulos e Valores Mobiliários SA 0.000004 %	1,036	0.000004 %	32 125 $
Banco Santander Brasil SA (Private Banking) 0.000001 %	276	0.000001 %	8 559 $

Name	Equities	%	Valuation
Krung Thai Asset Management Public Co., Ltd. 0.004417 %	4,159,950	0.004417 %	179 918 $

Breakdown by shareholder type

Institutional	88.67%
Other	6.27%
State Street Corp.	3.75%
Schweizerische Nationalbank	0.25%
Fifth Third Bancorp	0.21%
Sumitomo Mitsui Trust Group, Inc.	0.19%
Swedbank AB	0.17%
Individuals	0.17%
Manulife Financial Corp.	0.15%
Governments	0.12%
Danske Bank A/S	0.07%
SEI Investments Co.	0.07%
Rathbones Group Plc	0.04%
The Bank of Nova Scotia	0.04%
Regions Financial Corp.	0.03%
Menora Mivtachim Holdings Ltd.	0.03%
Polar Capital Holdings Plc	0.03%
ABN AMRO Bank NV	0.03%
Zurich Insurance Group AG	0.02%
ING Groep NV	0.02%
Münchener Rückversicherungs-Gesellschaft AG	0.01%
Associated Banc-Corp	0.01%
Migdal Insurance & Financial Holdings Ltd.	0.01%
Peapack-Gladstone Financial Corp.	0.01%
Banco Bilbao Vizcaya Argentaria SA	0.01%
The Allstate Corp.	0.01%
Clal Insurance Enterprises Holdings Ltd.	0.01%
Phoenix Financial Ltd.	0.01%
Cullen/Frost Bankers, Inc.	0.01%

Based on 1000 largest holdings

Geographical origin of shareholders

United States	83.74%
United Kingdom	7.21%
Canada	1.74%
Norway	1.4%
France	0.89%
Sweden	0.79%
Switzerland	0.61%
Australia	0.55%
Thailand	0.44%
Japan	0.37%
Germany	0.35%
Denmark	0.34%
Netherlands	0.34%
South Korea	0.25%
Luxembourg	0.23%
Hong Kong	0.22%
Individuals	0.17%
Ireland	0.11%
Italy	0.11%
Belgium	0.11%
Israel	0.07%
Finland	0.06%
Liechtenstein	0.05%
Spain	0.04%
Singapore	0.04%
Brazil	0.04%
New Zealand	0.03%
Malaysia	0.03%
Czech Republic	0.02%
Austria	0.02%
Russia	0.01%
Slovenia	0.01%
South Africa	0.01%
China	0.01%
Taiwan	0.01%

Based on 1000 largest holdings

Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows: - endocrinology (74%): products for treating osteoporosis, diabetes, and growth problems; - oncology (14.4%); - immunology diseases (8.1%); - neurology (2.1%): primarily drugs used in treating depression and schizophrenia; - other (1.4%). Net sales are distributed geographically as follows: the United States (66.7%), Europe (17.7%), Japan (3.2%), China (3%) and other (9.4%).

Employees

50,000

Sector

Pharmaceuticals

Calendar

05-15 - Ex-dividend date - 1.73 USD

More about the company